Inhibition of Aurora kinases enhances chemosensitivity to temozolomide and causes radiosensitization in glioblastoma cells

ZM 447439 inhibition of aurora kinase induces Hep2 cancer cell apoptosis in three-dimensional culture

(2011) Zi-Jie Long et al.   CELL CYCLE

Antimyeloma Activity of a Multitargeted Kinase Inhibitor, AT9283, via Potent Aurora Kinase and STAT3 Inhibition Either Alone or in Combination with Lenalidomide

(2011) L. Santo et al.   CLINICAL CANCER RESEARCH

Update on aurora kinase targeted therapeutics in oncology

(2011) Myke R Green et al.   Expert Opinion on Drug Discovery

Antiproliferative effects of Tubi-bee propolis in glioblastoma cell lines

(2011) Kleiton Silva Borges et al.   GENETICS AND MOLECULAR BIOLOGY

MLN8054, A Small Molecule Inhibitor of Aurora Kinase A, Sensitizes Androgen-Resistant Prostate Cancer to Radiation

(2011) Luigi Moretti et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Enhanced Radiosensitivity of Androgen-Resistant Prostate Cancer: AZD1152-Mediated Aurora Kinase B Inhibition

(2011) Kenneth J Niermann et al.   RADIATION RESEARCH

Aurora kinase inhibitors as anticancer molecules

(2010) Hiroshi Katayama et al.   Biochimica et Biophysica Acta-Gene Regulatory Mechanisms

Aurora A, Aurora B and survivin are novel targets of transcriptional regulation by histone deacetylase inhibitors in non-small cell lung cancer

(2010) Xu-Hui Zhang et al.   CANCER BIOLOGY & THERAPY

System-Level Analysis of Neuroblastoma Tumor-Initiating Cells Implicates AURKB as a Novel Drug Target for Neuroblastoma

(2010) O. Morozova et al.   CLINICAL CANCER RESEARCH

Aurora kinase A as a rational target for therapy in glioblastoma

(2010) Valerie N. Barton et al.   Journal of Neurosurgery-Pediatrics

ZM447439, the Aurora kinase B inhibitor, suppresses the growth of cervical cancer SiHa cells and enhances the chemosensitivity to cisplatin

(2010) Liya Zhang et al.   JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH

Antineoplastic effects of an Aurora B kinase inhibitor in breast cancer

(2010) Christopher P Gully et al.   Molecular Cancer

Activity of the Aurora Kinase Inhibitor VX-680 against Bcr/Abl-Positive Acute Lymphoblastic Leukemias

(2010) F. Fei et al.   MOLECULAR CANCER THERAPEUTICS

Advances in the Treatment of Malignant Gliomas

(2010) Mustafa Khasraw et al.   Current Oncology Reports

In vitroanti-myeloma activity of the Aurora kinase inhibitor VE-465

(2009) Joseph M. Negri et al.   BRITISH JOURNAL OF HAEMATOLOGY

Genetic alterations and signaling pathways in the evolution of gliomas

(2009) Hiroko Ohgaki et al.   CANCER SCIENCE

ZM447439, a Novel Promising Aurora Kinase Inhibitor, Provokes Antiproliferative and Proapoptotic Effects Alone and in Combination with Bio- and Chemotherapeutic Agents in Gastroenteropancreatic Neuroendocrine Tumor Cell Lines

(2009) I. Georgieva et al.   NEUROENDOCRINOLOGY

Clinical Experience with Aurora Kinase Inhibitors: A Review

(2009) D. S. Boss et al.   ONCOLOGIST

Comparative immunohistochemical analysis of aurora-A and aurora-B expression in human glioblastomas. Associations with proliferative activity and clinicopathological features

(2009) Vassilis Samaras et al.   PATHOLOGY RESEARCH AND PRACTICE

Expression of Aurora A (but Not Aurora B) Is Predictive of Survival in Breast Cancer

(2008) Y. Nadler et al.   CLINICAL CANCER RESEARCH

Effects of the aurora kinase inhibitors AZD1152-HQPA and ZM447439 on growth arrest and polyploidy in acute myeloid leukemia cell lines and primary blasts

(2008) E. Walsby et al.   HAEMATOLOGICA

The Aurora kinase inhibitor VE-465 has anticancer effects in pre-clinical studies of human hepatocellular carcinoma

(2008) Zhong-Zhe Lin et al.   JOURNAL OF HEPATOLOGY

Gene expression profile analysis of primary glioblastomas and non-neoplastic brain tissue: identification of potential target genes by oligonucleotide microarray and real-time quantitative PCR

(2008) Carlos A. Scrideli et al.   JOURNAL OF NEURO-ONCOLOGY

Polyploidy in atypical grade II choroid plexus papilloma of the posterior fossa

(2008) María Sol Brassesco et al.   NEUROPATHOLOGY